Business & Management
Global

Business & Management Experts

James D. (j.d.) Weir

PRESIDENT & CEO
Management
Primus pharmaceuticals
United States of America

Biography

Mr. Weir founded Primus in 2001 as the first specialty pharmaceutical company to focus on prescription medical food brands using proprietary ingredient platforms targeting major chronic diseases with metabolic etiologies. Prior to Primus, Mr. Weir led drug and medical device businesses for Procter & Gamble (P&G) and Kendall-Futuro. As a marketing executive with P&G, he managed OTC businesses such as Crest® and later prescription drugs such as the leading osteoporosis drug Actonel® and the hypertension drug Ziac®. As a Vice President at Kendall-Futuro, Mr. Weir managed commercial operations, including marketing and product development, as well as the company's successful turnaround. Kendall-Futuro had the Curad®, Curity®, Telfa®, Kerlix®, TED®, and Futuro® wound care, venous compression and durable medical equipment product lines. He was instrumental in leading the sale of Kendall-Futuro to German multi-national Beiersdorf AG. He subsequently led brand development and start-up commercialization for Esurance, which was sold to Allstate in 2011. Mr. Weir began his career as a CPA with Deloitte. Mr. Weir graduated with honors from Harvard Business School with an MBA and from Augustana College cum laude with a BS in Business and Accounting. Mr. Weir founded Primus in 2001 as the first specialty pharmaceutical company to focus on prescription medical food brands using proprietary ingredient platforms targeting major chronic diseases with metabolic etiologies. Prior to Primus, Mr. Weir led drug and medical device businesses for Procter & Gamble (P&G) and Kendall-Futuro. As a marketing executive with P&G, he managed OTC businesses such as Crest® and later prescription drugs such as the leading osteoporosis drug Actonel® and the hypertension drug Ziac®. As a Vice President at Kendall-Futuro, Mr. Weir managed commercial operations, including marketing and product development, as well as the company's successful turnaround. Kendall-Futuro had the Curad®, Curity®, Telfa®, Kerlix®, TED®, and Futuro® wound care, venous compression and durable medical equipment product lines. He was instrumental in leading the sale of Kendall-Futuro to German multi-national Beiersdorf AG. He subsequently led brand development and start-up commercialization for Esurance, which was sold to Allstate in 2011. Mr. Weir began his career as a CPA with Deloitte. Mr. Weir graduated with honors from Harvard Business School with an MBA and from Augustana College cum laude with a BS in Business and Accounting.

Research Interest

Business and Accounting

Global Experts from United States of America

Global Experts in Subject

Share This Profile